HemeRetic
| Primary Site | Histology | Behavior | Schema Discriminator 1 | Year of Diagnosis |
|---|---|---|---|---|
| C000-C440, C442-C689, C691-C694, C698-C699, C739-C749, C750, C754-C759, C760-C809 | 9591 | <Any value> | 1, 2 | <Any value> |
| C700-C729, C751-C753 | 9591 | 3 | 1, 2 | <Any value> |
| C000-C699, C739-C750, C754-C809 | 9724, 9727, 9740-9742, 9749, 9762-9809, 9811-9820, 9831-9920, 9931-9993 | <Any value> | <Any value> | <Any value> |
| C700-C729, C751-C753 | 9724, 9727, 9740-9742, 9762-9765, 9767-9809, 9811-9820, 9831-9920, 9931-9993 | 3 | <Any value> | <Any value> |
| C700-C729, C751-C753 | 9749, 9766 | 3 | <Any value> | 2018-2022 |
| C000-C699, C739-C750, C754-C809 | 9751, 9755-9759 | <Any value> | <Any value> | <Any value> |
| C000-C440, C442-C689, C691-C694, C698-C699, C739-C750, C754-C809 | 9930 | <Any value> | <Any value> | <Any value> |
| C700-C729, C751-C753 | 9930 | 3 | <Any value> | <Any value> |
Notes
9724, 9727, 9740-9742, 9749, 9762-9809, 9811-9820, 9831-9920, 9931-9993 * C700-C729, C751-C753 for 9749, 9766 (2018-2022 only) (See Note 2) C000-C440, C442-C689, C691-C694, C698-C809: 9591 and Schema Discriminator 1: 1, 2 C000-C699, C739-C750, C754-C809: 9751, 9755-9759 C000-C440, C442-C689, C691-C694, C698-C809: 9930 **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 83 *Leukemia*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** For the histologies and primary sites listed below, these have moved to the Brain, CNS Other, and Intracranial Gland schemas starting with 2023 diagnoses.. If you have one of these cases for 2018-2022, then this is the appropriate schema. If you have one of these cases diagnosed on January 1, 2023 forward, see the appropriate schema * 9749, 9766 * C700, C710-C719: *Brain* * C701, C709, C720-C725, C728-C729: *CNS Other* * C751-C753: *Intracranial Gland* **Note 3:** See the following schemas for the listed histologies * 9591 and Schema Discriminator 1: 3, 9 (C000-C440, C442-C689, C691-C694, C698-C809): *Lymphoma * 9751, 9755-9759 (C700, C710-C719): *Brain* * 9751, 9755-9759 (C701, C709, C720-C725, C728-C729): *CNS Other* * 9751, 9755-9759 (C751-C753): *Intracranial Gland* * 9930 (C441, C690, C695-C696): *Lymphoma Ocular Adnexa* **Note 4:** Summary Stage is the only applicable staging system for this site/histology/schema. **Note 5:** See list of specific histologies below, effective for cases diagnosed 2010 and forward. All primary sites (C000-C809) are included unless otherwise specified. **Note 6:** Schema includes the preferred terms based on the *2017 WHO Classification of Haematopoietic and Lymphoid Tissues* 9591 Splenic B-cell lymphoma/leukemia, unclassifiable (except C441, C690, C695-C696) 9724 Systemic EBV-positive T-cell lymphoma of childhood 9727 Blastic plasmacytoid dendritic cell neoplasm 9740 Mast cell sarcoma 9741 Systemic mastocytosis with an associated hematological neoplasm 9742 Mast cell leukemia 9749 Erdheim-Chester disease (2021+ only) (except C700-C729, C751-C753 for 1/1/2023+) 9751 Langerhans cell histiocytosis, disseminated (except C700-C729, C751-C753) 9755 Histiocytic sarcoma (except C700-C729, C751-C753) 9756 Langerhans cell sarcoma (except C700-C729, C751-C753) 9757 Interdigitating dendritic cell sarcoma (except C700-C729, C751-C753) 9758 Follicular dendritic cell sarcoma (except C700-C729, C751-C753) 9759 Fibroblastic reticular cell tumor (except C700-C729, C751-C753) 9762 Heavy chain diseases 9766 Lymphomatoid granulomatosis, Grade 3 (2021+ only) (except C700-C729, C751-C753 for 1/1/2023+) 9800 Leukemia, NOS 9801 Acute undifferentiated leukemia 9806 Mixed-phenotype acute leukemia with t(9;22)(q34.1;q11.2); *BCR-ABL1* 9807 Mixed-phenotype acute leukemia with t(v;11q23.3); *KMT2A*-rearranged 9808 Mixed -phenotype acute leukemia, B/myeloid, NOS 9809 Mixed-phenotype acute leukemia, T/myeloid, NOS 9811 B-lymphoblastic leukemia/lymphoma, NOS 9812 B-lymphoblastic leukemia/lymphoma with t(9;22))q34.1;q11.2); *BCR-ABL1* 9813 B-lymphoblastic leukemia/lymphoma with t(v;11q23.3); *KMT2A*-rearranged 9814 B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1); *ETV6-RUNX1* 9815 B-lymphoblastic/lymphoma with hyperdiploidy 9816 B-lymphoblastic/lymphoma with hypodiploidy (hypodiploid ALL) 9817 B-lymphoblastic/lymphoma with t(5;14)(q31.1;q32.1); IGH/*IL3* 9818 B-lymphoblastic/lymphoma with t(1;19)(q23;p13.3); *TCF3-PBX1* 9819 B-lymphoblastic/lymphoma, BCR-ABL1 like (2021+ only) 9820 Lymphoid leukemia, NOS 9831 T-cell large granular lymphocytic leukemia 9832 Prolymphocytic leukemia, NOS 9833 B-cell prolymphocytic leukemia 9834 T-cell prolymphocytic leukemia 9837 T-lymphoblastic leukemia/lymphoma 9840 Pure erythroid leukemia 9860 Myeloid leukemia, NOS 9861 Acute myeloid leukemia, NOS 9863 Chronic myeloid leukemia 9865 Acute myeloid leukemia with t(6;9)(p23;q34.1); *DEK-NUP214* 9866 Acute promyelocytic leukemia with *PML-RARA* 9867 Acute myelomonocytic leukemia 9869 Acute myeloid leukemia with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26;2); *RBM15-MKL1* 9870 Acute basophilic leukemia 9871 Acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); *CBFB-MYH11* 9872 Acute myeloid leukemia, minimal differentiation 9873 Acute myeloid leukemia without maturation 9874 Acute myeloid leukemia with maturation 9875 Chronic myeloid leukemia, *BCR-ABL1*-positive 9876 Atypical chronic myeloid leukemia *BCR-ABL1*-negative 9877 Acute myeloid leukemia with mutated NPM1 (2021+ only) 9878 Acute myeloid leukemia with biallelic mutation of CEBPA (2021+ only) 9879 Acute myeloid leukemia with mutated RUNX1 (2021+ only) 9891 Acute monoblastic and monocytic leukemia 9895 Acute myeloid leukemia with myelodysplasia-related changes 9896 Acute myeloid leukemia with t(8;21)(q22;q22.1), *RUNX1-RUNX1T1* 9897 Acute myeloid leukemia with t(9;11)(p21.3;q23.3); *KMT2A-MLLT3* 9898 Myeloid leukemia associated with Down Syndrome 9910 Acute megakaryoblastic leukemia 9911 Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13.3;q13.1); *RBM15-MKL1* 9912 Acute myeloid leukemia with BCR-ABL1 (2021+ only) 9920 Therapy-related myeloid neoplasms 9930 Myeloid sarcoma (except C441, C690, C695-C696) 9931 Acute panmyelosis with myelofibrosis 9940 Hairy cell leukemia 9945 Chronic myelomonocytic leukemia, NOS 9946 Juvenile myelomonocytic leukemia 9948 Aggressive NK-cell leukemia 9950 Polycythemia vera 9961 Primary myelofibrosis 9962 Essential thrombocythemia 9963 Chronic neutrophilic leukemia 9964 Chronic eosinophilic leukemia, NOS 9965 Myeloid/lymphoid neoplasms with *PDGFRA* rearrangement 9966 Myeloid/lymphoid neoplasm with *PDGFRB* rearrangement 9967 Myeloid/lymphoid neoplasm with *FGFR1* rearrangement 9968 Myeloid/lymphoid neoplasm with PCM1-JAK2 (2021+ only) 9971 Polymorphic PTLD (2018-2020 only, nonreportable as of 2021) 9975 Myelodysplastic/myeloproliferative neoplasm, unclassifiable 9980 Myelodysplastic syndrome with single lineage dysplasia 9982 Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia 9983 Myelodysplastic syndrome with excess blasts 9985 Myelodysplastic syndrome with multilineage dysplasia 9986 Myelodysplastic syndrome with isolated del(5q) 9989 Myelodysplastic syndrome, unclassifiable 9991 Refractory neutropenia (2018-2020 only, see code 9980/3 for 2021+) 9992 Refractory thrombocytopenia (2018-2020 only, see code 9980/3 for 2021+) 9993 Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia (2021+)Data Items
| Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
|---|---|---|---|---|---|
| Year of Diagnosis | <BLANK> | Yes |
NAACCR #390
dateOfDiagnosis |
None | |
| Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
| Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
| Behavior | <BLANK> | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | |
| Schema Discriminator 1 | <BLANK> | Yes |
NAACCR #3926
schemaDiscriminator1 |
All | SSDI |
| Age at Diagnosis | <BLANK> | Yes |
NAACCR #230
ageAtDiagnosis |
None | |
| Tumor Size Clinical | 999 | No |
NAACCR #752
tumorSizeClinical |
None | |
| Tumor Size Pathological | 999 | No |
NAACCR #754
tumorSizePathologic |
None | |
| Tumor Size Summary | 999 | No |
NAACCR #756
tumorSizeSummary |
None | |
| Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
| Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
| EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
| EOD Regional Nodes | 888 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
| EOD Mets | 88 | Yes |
NAACCR #776
eodMets |
None | |
| SS2018 | <BLANK> | No |
NAACCR #764
summaryStage2018 |
None | |
| Grade Clinical | 8 | Yes |
NAACCR #3843
gradeClinical |
All | SSDI |
| Grade Pathological | 8 | Yes |
NAACCR #3844
gradePathological |
All | SSDI |
| Grade Post Therapy Clin (yc) | <BLANK> | No |
NAACCR #1068
gradePostTherapyClin |
COC NPCR SEER |
SSDI |
| Grade Post Therapy Path (yp) | <BLANK> | No |
NAACCR #3845
gradePostTherapy |
CCCR/Canada COC NPCR SEER |
SSDI |
| JAK2 | 8 | No |
NAACCR #3862
jak2 |
COC SEER |
SSDI |
Initial Context
Outputs
| Name | Default Value | Description | NAACCR Item | Metadata |
|---|---|---|---|---|
| Schema ID | 00830 |
NAACCR #3800
schemaId |
None | |
| Derived Version | {{ctx_alg_version}} | None | None | |
| Derived Summary Stage 2018 | 9 |
NAACCR #762
derivedSummaryStage2018 |
None | |
| Derived Summary Grade 2018 | <BLANK> |
NAACCR #1975
derivedSummaryGrade2018 |
None |